Obermatt
See Similar Stocks →

Flags

Financial distress

Neuronetics

NMQ:STIM · US64131A1051
Health Care Equipment & SuppliesSmall

360

46
Profit price44
Owner Earnings Yield1
Dividend Yield1
Price/Sales95
EV / Gross Profit76
Price/Book85
Return on Capital39
Cash Return on Capital38
Return on Equity14
EBIT Margin38
Gross Profitability75
Accruals89
Owner Earnings Margin39
Sales growth39
Profit growth29
Reinvestment21
Price momentum5
Debt load5
Refinancing77
Debt Payback1
Liquidity43
Analyst ratings38
Opinion Changes50
Price Target Upside98
Market mood3
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Neuronetics doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2001
Employees203
Websiteneurostar.com/neuronetics
ISINUS64131A1051
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
PsychiatryDigital Mental HealthNeurologyNeuroscienceCentral Nervous SystemBiotechnologyHealth CareScience and Engineering

Description

Neuronetics, Inc. engages in providing in-office treatments for patients with neurohealth disorders. The company's first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses t…

Analysis

Middle-of-the-road

Neuronetics, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
10
2023202420252026

All-time high

76

Jan 2023

All-time low

8

Mar 2026

Average rank

32

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
95
43
81
89
Price/Earnings
63
46
46
46
Price/Book
85
11
64
92
Dividend Yield
1
1
1
1
Value (overall)
96
25
62
79

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Neuronetics with its peers
Sensus Healthcare
NAQ:SRTS
54
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Pulmonx
NSQ:LUNG
56
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
NeuroPace
NMQ:NPCE
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Heartbeam
NAQ:BEAT
10
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Kestra Medical Technologies
NSQ:KMTS
21
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Microbot Medical
NAQ:MBOT
16
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →